Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Pharmacogenetics Implementation Consortium | RCV000782432 | SCV000920955 | drug response | CYP2C19: no function | practice guideline | curation | ||
Eurofins Ntd Llc |
RCV000383294 | SCV000331712 | other | not provided | 2015-12-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000383294 | SCV000971805 | likely benign | not provided | 2018-03-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
OMIM | RCV000018399 | SCV000038681 | drug response | Mephenytoin, poor metabolism of | 1998-01-01 | no assertion criteria provided | literature only |